Cargando…

How to optimize the treatment of early stage Parkinson’s disease

The approach to early Parkinson’s disease denotes the communication of the diagnosis and important decisions, such as when and how to start treatment. Evidence based medicine and guidelines indicate which drugs have robust evidence of efficacy and tolerability in this specific population. However, d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stocchi, Fabrizio, Vacca, Laura, Radicati, Fabiana G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429368/ https://www.ncbi.nlm.nih.gov/pubmed/25973179 http://dx.doi.org/10.1186/2047-9158-4-4

Ejemplares similares

Clinical assessment of a new wearable tool for continuous and objective recording of motor fluctuations and ON/OFF states in patients with Parkinson’s disease
por: Battista, Luigi, et al.
Publicado: (2023)

Applications of the European Parkinson’s Disease Association sponsored Parkinson’s Disease Composite Scale (PDCS)
por: Balestrino, Roberta, et al.
Publicado: (2019)

Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control study
por: Torti, Margherita, et al.
Publicado: (2020)

Non motor symptoms in progressive supranuclear palsy: prevalence and severity
por: Radicati, Fabiana Giada, et al.
Publicado: (2017)

The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease
por: Abbruzzese, Giovanni, et al.
Publicado: (2021)

Utility of tolcapone in fluctuating Parkinson’s disease
por: Stocchi, Fabrizio, et al.
Publicado: (2006)

Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
por: Stocchi, Fabrizio, et al.
Publicado: (2016)

L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study
por: Stocchi, Fabrizio, et al.
Publicado: (2015)

Treatment of Parkinson’s disease in the advanced stage
por: Ossig, C., et al.
Publicado: (2013)

A Stage-Based Approach to Therapy in Parkinson’s Disease
por: Carrarini, Claudia, et al.
Publicado: (2019)

The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease
por: Stephenson, Diane, et al.
Publicado: (2019)

Optimizing Treatment of Parkinson’s Disease
por: Nyholm, Dag, et al.
Publicado: (2022)

Therapeutic education for empowerment and engagement in patients with Parkinson’s disease: A non-pharmacological, interventional, multicentric, randomized controlled trial
por: De Pandis, Maria Francesca, et al.
Publicado: (2023)

Treatment of the later stages of Parkinson’s disease – pharmacological approaches now and in the future
por: Jenner, Peter
Publicado: (2015)

Impact of Tremor on Patients With Early Stage Parkinson's Disease
por: Heusinkveld, Lauren E., et al.
Publicado: (2018)

Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus
por: Stocchi, Fabrizio, et al.
Publicado: (2022)

Microbiome, Parkinson’s Disease and Molecular Mimicry
por: Miraglia, Fabiana, et al.
Publicado: (2019)

Frontostriatal Cognitive Staging in Parkinson's Disease
por: de la Fuente-Fernández, Raúl
Publicado: (2012)

Optimal treatment of early-stage ovarian cancer
por: Collinson, F., et al.
Publicado: (2014)

Access to device-aided therapies in advanced Parkinson’s disease: navigating clinician biases, patient preference, and prognostic uncertainty
por: Auffret, Manon, et al.
Publicado: (2023)

Feasibility of home dose optimization of apomorphine sublingual film in Parkinson’s disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study
por: Kassubek, Jan, et al.
Publicado: (2023)

Nonmotor Symptoms in Early- and Advanced-Stage Parkinson's Disease Patients on Dopaminergic Therapy: How Do They Correlate with Quality of Life?
por: Valkovic, Peter, et al.
Publicado: (2014)

Hematopoietic cytokines as therapeutic players in early stages Parkinson’s disease
por: Farmer, Kyle, et al.
Publicado: (2015)

Methods for Surgical Targeting of the STN in Early-Stage Parkinson’s Disease
por: Camalier, Corrie R., et al.
Publicado: (2014)

Predictors of Mild Cognitive Impairment in Early-Stage Parkinson's Disease
por: Hanna-Pladdy, Brenda, et al.
Publicado: (2013)

Predictors of cognitive impairment in an early stage Parkinson’s disease cohort
por: Hu, Michele T M, et al.
Publicado: (2014)

Stability of motor-nonmotor subtype in early-stage Parkinson’s disease
por: Xiao, Yi, et al.
Publicado: (2022)

Non-Motor Symptoms Burden in Early Stages of Parkinson's Disease
por: Sardar, Zomer, et al.
Publicado: (2023)

Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease
por: Yan, Zhaoqi, et al.
Publicado: (2021)

Classification of advanced stages of Parkinson’s disease: translation into stratified treatments
por: Krüger, Rejko, et al.
Publicado: (2017)

Challenges and Perspectives in the Management of Late-Stage Parkinson’s Disease
por: Fabbri, Margherita, et al.
Publicado: (2020)

Proposal for a Biologic Staging System of Parkinson’s Disease
por: Chahine, Lana M., et al.
Publicado: (2023)

Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease
por: Pachi, Ioanna, et al.
Publicado: (2023)

How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage
por: Izumiya, Yasuhiro, et al.
Publicado: (2020)

Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson’s Disease
por: Lamonaca, Giulia, et al.
Publicado: (2020)

GBA Variants and Parkinson Disease: Mechanisms and Treatments
por: Smith, Laura, et al.
Publicado: (2022)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson’s disease
por: Hametner, Eva-Maria, et al.
Publicado: (2012)

Anorectal Manometric Dysfunctions in Newly Diagnosed, Early-Stage Parkinson's Disease
por: Sung, Hye Young, et al.
Publicado: (2012)

Oscillation-specific nodal alterations in early to middle stages Parkinson’s disease
por: Guan, Xiaojun, et al.
Publicado: (2019)

The role of brain perivascular space burden in early-stage Parkinson’s disease
por: Shen, Ting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1n84dm34ndcupgpo7fjb10nmvl